Access to Investigational Therapies
Patients may qualify for medications not yet available in standard practice, including therapies targeting heart failure, atherosclerotic cardiovascular disease, lipoprotein(a), cardiometabolic risk, and inflammation-driven cardiovascular conditions.
Enhanced Monitoring and Follow-Up
Participants receive regular assessments, ECGs, lab work, and close oversight from cardiologists and certified research staff.
No Cost to Patients
All study-related visits, tests, and medications are provided at no cost. Parking reimbursement may be available for eligible participants.
Collaborative Care
We keep referring clinicians informed and involved. Our goal is to complement — not replace — your ongoing care.